Cargando…
Detection of HER-2/neu-positive circulating epithelial cells in prostate cancer patients
HER-2/neu may play a role in prostate carcinogenesis. The aim of this study was to use the expression of HER-2/neu as a molecular marker for the detection of circulating tumour cells (CTCs) in the blood of patients with prostate cancer (PC). Blood samples were collected from 42 patients with PC and...
Autores principales: | Ady, N, Morat, L, Fizazi, K, Soria, J-C, Mathieu, M-C, Prapotnich, D, Sabatier, L, Chauveinc, L |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409539/ https://www.ncbi.nlm.nih.gov/pubmed/14735191 http://dx.doi.org/10.1038/sj.bjc.6601532 |
Ejemplares similares
-
Cytotoxic T-cell precursor frequencies to HER-2 (369 – 377) in patients with HER-2/neu-positive epithelial tumours
por: Sotiropoulou, P A, et al.
Publicado: (2003) -
Differential expression of telomerase reverse transcriptase (hTERT) in lung tumours
por: Lantuejoul, S, et al.
Publicado: (2004) -
Evaluation of HER-2/neu gene amplification and protein expression in non-small cell lung carcinomas
por: Hirsch, F R, et al.
Publicado: (2002) -
HER2/neu overexpression in the development of muscle-invasive transitional cell carcinoma of the bladder
por: Latif, Z, et al.
Publicado: (2003) -
Clinical significance of Caveolin-1, Caveolin-2 and HER2/neu mRNA expression in human breast cancer
por: Sagara, Y, et al.
Publicado: (2004)